Peran Vitamin D Terhadap Kanker: Sebuah Tinjauan Literatur

Zahra Umami, Suharjono Suharjono

Abstract


Vitamin D is a potent steroid hormone precursor that regulates a broad spectrum of physiological processes in the body. Besides its general role in bone metabolism, vitamin D plays an important role in the prevention and treatment of many diseases such as cancer.
The aim of this literature review is to examine in more depth the role of vitamin D as an anticancer. There are studies that reveal biological mechanisms mediated by vitamin D in regulating cancer cells, such as cell renewal, cell proliferation, cell differentiation, cell transformation, and cell death. Other studies have also revealed a link between the immune system and the anti-neoplastic effects of vitamin D. Research shows that low levels of vitamin D in circulation are associated with an increased risk of cancer. The use of supplementation alone or in combination with immunotherapy or other chemotherapy may
promote better clinical outcomes. These promising results still require further development and research through novel approaches targeting vitamin D signaling and metabolic systems to improve cancer therapeutic outcomes.

Full Text:

PDF

References


1. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, et al. Vitamin D and Chronic Diseases. Aging Dis. 2017;8(3):346.

2. Leung MF, Cheung PCK. Vitamins D and D2 in Cultivated Mushrooms under Ultraviolet Irradiation and Their Bioavailability in Humans: A Mini[1]Review. Int J Med Mushrooms. 2021;23(11):1–15.

3. Feldman D, Krishnan A V., Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014 May 4;14(5):342–57.

4. Zhou R, Chun RF, Lisse TS, Garcia AJ, Xu J, Adams JS, et al. Vitamin D and alternative splicing of RNA. J Steroid Biochem Mol Biol. 2015 Apr;148:310– 7.

5. Bikle DD. Extraskeletal actions of vitamin D. Ann N Y Acad Sci. 2016 Jul 20;1376(1):29–52.

6. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling‐Perry K, Gales B, et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐ dihydroxyvitamin D in human monocytes. Journal of Bone and Mineral Research. 2013 Jan 18;28(1):46–55.

7. Lisse TS, Chun RF, Rieger S, Adams JS, Hewison M. Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. Journal of Bone and Mineral Research. 2013 Jun 21;28(6):1478–88.

8. Verma A, Vincent-Chong V, DeJong H, Hershberger P, Seshadri M. Impact of Dietary Vitamin D on Initiation and Progression of Oral Cancer. Journal of Steroid Biochemistry and Molecular Biology. 2020;199.

9. Zhang X, Luo F, Li J, Wan J, Zhang L, Li H, et al. DNA damage‐inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti‐carcinoma effect of 1,25(OH)2D3. Exp Dermatol. 2019 Jan 5;28(1):45–52.

10. Giammanco M, Di Majo D, La Guardia M, Aiello S, Crescimannno M, Flandina C, et al. Vitamin D in cancer chemoprevention. Pharm Biol. 2015 Oct 3;53(10):1399–434.

11. El-Sharkawy A, Malki A. Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications. Molecules. 2020 Jul 15;25(14):3219.

12. Xie DD, Chen YH, Xu S, Zhang C, Wang DM, Wang H, et al. Low vitamin D status is associated with inflammation in patients with prostate cancer. Oncotarget. 2017 Mar 28;8(13):22076–85.

13. Stroomberg HV, Vojdeman FJ, Madsen CM, Helgstrand JT, Schwarz P, Heegaard AM, et al. Vitamin D levels and the risk of prostate cancer and prostate cancer mortality. Acta Oncol (Madr). 2021 Apr 3;60(3):316– 22.

14. Qin W, Smith C, Jensen M, Holick MF, Sauter ER. Vitamin D favorably alters the cancer promoting prostaglandin cascade. Anticancer Res. 2013 Sep;33(9):3861–6.

15. Liu W, Zhang L, Xu HJ, Li Y, Hu CM, Yang JY, et al. The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis. Int J Mol Sci. 2018 Sep 13;19(9):2736.

16. Wang Q, He Y, Shen Y, Zhang Q, Chen D, Zuo C, et al. Vitamin D Inhibits COX-2 Expression and Inflammatory Response by Targeting Thioesterase Superfamily Member 4. Journal of Biological Chemistry. 2014 Apr;289(17):11681–94.

17. Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D Receptor Inhibits Nuclear Factor κB Activation by Interacting with IκB Kinase β Protein. Journal of Biological Chemistry. 2013 Jul;288(27):19450–8.

18. Rong K, He Q, Chen S, Yu Y, Mei L, Mi Y, et al. The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology. Front Pharmacol. 2023 May 17;14.

19. Slominski AT, Brożyna AA, Skobowiat C, Zmijewski MA, Kim TK, Janjetovic Z, et al. On the role of classical and novel forms of vitamin D in melanoma progression and management. J Steroid Biochem Mol Biol. 2018 Mar;177:159–70.

20. Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018 Apr 16;50(4):1– 14.

21. Song J, Sun H, Zhang S, Shan C. The Multiple Roles of Glucose-6- Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance. Life. 2022 Feb 12;12(2):271.

22. Wang EW, Collins AR, Pang MYC, Siu PPM, Lai CKY, Woo J, et al. Vitamin D and oxidation-induced DNA damage: is there a connection? Mutagenesis. 2016 Nov;31(6):655–9.

23. O’Brien KM, Sandler DP, Xu Z, Kinyamu HK, Taylor JA, Weinberg CR. Vitamin D, DNA methylation, and breast cancer. Breast Cancer Research. 2018 Dec 11;20(1):70.

24. Ji M, Liu L, Hou Y, Li B. 1α,25-Dihydroxyvitamin D3 restrains stem cell-like properties of ovarian cancer cells by enhancing vitamin D 91 Peran Vitamin D Terhadap Kanker: Sebuah Tinjauan Literatur Journal of Islamic Medicine, Volume 8, Number 2, September, 2024 receptor and suppressing CD44. Oncol Rep. 2019 Jun 1;41(6):3393–403.

25. Fernández-Barral A, Bustamante[1]Madrid P, Ferrer-Mayorga G, Barbáchano A, Larriba MJ, Muñoz A. Vitamin D Effects on Cell Differentiation and Stemness in Cancer. Cancers (Basel). 2020 Aug 25;12(9):2413.

26. Nemeth Z, Patonai A, Simon-Szabó L, Takács I. Interplay of Vitamin D and SIRT1 in Tissue-Specific Metabolism—Potential Roles in Prevention and Treatment of Non[1]Communicable Diseases Including Cancer. Int J Mol Sci. 2023 Mar 24;24(7):6154.

27. safarzadeh gargari samad, matin homaei hassan, azarbayjani mohamad ali. The response of BAX, BCL-2 ratio to vitamin D consumption with concurrent training in rat males. Medical Journal of Tabriz University of Medical Sciences and Health Services. 2020 May 19;42(2):194–9.

28. Sergeev IN. Vitamin D-mediated apoptosis in cancer and obesity. Horm Mol Biol Clin Investig. 2014 Nov 1;20(2):43–9.

29. Fenner A. Calcium promotes cancer; vitamin D decelerates. Nat Rev Urol. 2017 Feb 6;14(2):68–68.

30. Sharma K, Goehe RW, Di X, Hicks MA, Torti S V, Torti FM, et al. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089. Autophagy. 2014 Dec 2;10(12):2346– 61.

31. Buthia SK. Vitamin D in Autophagy Signaling for Health and Diseases: Insights on Potential Mechanisms and Future Perspectives. J Nutr Biochem. 2022 Jan;99:108841.

32. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15–23.

33. Rosso C, Fera N, Murugan NJ, Voutsadakis IA. Vitamin D Levels in Newly Diagnosed Breast Cancer Patients according to Tumor Sub[1]Types. J Diet Suppl. 2023 Nov 2;20(6):926–38.

34. Alnimer A, Bhamidimarri PM, Talaat IM, Alkhayaal N, Eltayeb A, Ali N, et al. Association Between Expression of Vitamin D Receptor and Insulin-Like Growth Factor 1 Receptor Among Breast Cancer Patients. World J Oncol. 2023 Feb;14(1):67–74.

35. Segovia-Mendoza M, García-Quiroz J, Díaz L, García-Becerra R. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update. Int J Mol Sci. 2021 Nov 25;22(23):12741.

36. Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE, et al. Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers (Basel). 2022 Apr 29;14(9):2230.

37. Jung S, Jin S, Je Y. Vitamin D Intake, Blood 25-Hydroxyvitamin D, and Risk of Ovarian Cancer: A Meta-Analysis of Observational Studies. J Womens Health. 2023 May 1;32(5):561–73.

38. Lin D, Wang M, Chen Y, Gong J, Chen L, Shi X, et al. Trends in Intracranial Glioma Incidence and Mortality in the United States, 1975-2018. Front Oncol. 2021 Nov 1;11.

39. BAK DH, KANG SH, CHOI DR, GIL MN, YU KS, JEONG JH, et al. Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy. Exp Ther Med. 2016 Jun;11(6):2153–62.

40. Hu P, Li S, Tian N, Wu F, Hu Y, Li D, et al. Acidosis enhances the self[1]renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death Dis. 2019 Jan 10;10(1):25.

41. Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front Public Health. 2022 Feb 16;10.

42. Garcia J, Krieger KD, Loitz C, Perez LM, Richards ZA, Helou Y, et al. Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men. Cancer Research Communications. 2023 Mar 3;3(3):371–82.

43. Erzurumlu Y, Aydogdu E, Dogan HK, Catakli D, Muhammed MT, Buyuksandic B. 1,25(OH)2 D3 induced vitamin D receptor signaling negatively regulates endoplasmic reticulum-associated degradation (ERAD) and androgen receptor signaling in human prostate cancer cells. Cell Signal. 2023 Mar;103:110577.

44. Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Medical Sciences. 2020 Mar 13;8(1):15.

45. Özgen Ö, Özen Eroğlu G, Küçükhüseyin Ö, Akdeniz N, Hepokur C, Kuruca S, et al. Vitamin D increases the efficacy of cisplatin on bladder cancer cell lines. Mol Biol Rep. 2023 Jan 12;50(1):697–706.

46. Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT J. 2018 Apr 9;4:12.

47. Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021 Mar;500:1–10.

48. Litchfield K, Reading JL, Lim EL, Xu H, Liu P, Al-Bakir M, et al. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nat Commun. 2020 Jul 30;11(1):3800.

49. Capobianco E, McGaughey V, Seraphin G, Heckel J, Rieger S, Lisse TS. Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition. Front Oncol. 2023 May 9;13.

50. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterology Review. 2019;14(2):89–103.

51. Paulsen EM, Rylander C, Brustad M, Jensen TE. Pre-diagnostic intake of vitamin D and incidence of colorectal cancer by anatomical subsites: the Norwegian Women and Cancer Cohort Study (NOWAC). British Journal of Nutrition. 2023 Sep 28;130(6):1047– 55.

52. Sadeghi H, Hashemnia V, Nazemalhosseini-Mojarad E, Ghasemi MR, Mirfakhraie R. Correlated downregulation of VDR and CYP3A4 in colorectal cancer. Mol Biol Rep. 2023 Feb 5;50(2):1385–91.

53. Gibbs DC, Barry EL, Fedirko V, Baron JA, Bostick RM. Impact of Common Vitamin D–Binding Protein Isoforms on Supplemental Vitamin D 3 and/or Calcium Effects on Colorectal Adenoma Recurrence Risk. JAMA Oncol. 2023 Apr 1;9(4):546.

54. Guo S, Zhao W, Zhang W, Li S, Teng G, Liu L. Vitamin D Promotes Ferroptosis in Colorectal Cancer Stem Cells via SLC7A11 Downregulation. Oxid Med Cell Longev. 2023 Feb 16;2023:1–16.

55. Zhang Y, Zhang J, Xia Y, Sun J. Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis. Neoplasia. 2023 Jan;35:100847.

56. Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R. Vitamin D and breast cancer: Emerging concepts. Cancer Lett. 2013 Jun;334(1):95–100. Umami, Zahra dan Suharjono 93 Peran Vitamin D Terhadap Kanker: Sebuah Tinjauan Literatur Journal of Islamic Medicine, Volume 8, Number 2, September, 2024

57. Chen J, Wang J, Kim TK, Tieu E, Tang EKY, Lin Z, et al. Novel Vitamin D Analogs as Potential Therapeutics: Metabolism, Toxicity Profiling, and Antiproliferative Activity. Anticancer Res. 2014 May;34(5):2153–63.

58. Luo W, Hershberger PA, Trump DL, Johnson CS. 24-Hydroxylase in cancer: Impact on vitamin D-based anticancer therapeutics. J Steroid Biochem Mol Biol. 2013 Jul;136:252–7.

59. Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, et al. Effect of Vitamin D 3 Supplements on Development of Advanced Cancer. JAMA Netw Open. 2020 Nov 18;3(11):e2025850.

60. Lisse TS. Vitamin D Regulation of a SOD1-to-SOD2 Antioxidative Switch to Prevent Bone Cancer. Applied Sciences. 2020 Apr 8;10(7):2554.




DOI: https://doi.org/10.18860/jim.v8i2.26058

Refbacks

  • There are currently no refbacks.


 

Editorial Office:

Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 8563588384, Faximile (+62) 341 558933
e-mail: medicaljournal@uin-malang.ac.id


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.